clove and Inflammatory-Bowel-Diseases

Two new galloyl glucosides, galloyl-lawsoniaside A (4) and uromyrtoside (6), were isolated from the polar fraction of Uromyrtus metrosideros leaf extract along with another four previously identified phytochemicals (1, 2, 3, and 5). The structures of these six compounds were characterised using low and high-resolution mass spectrometry (L/HRMS) and 1D and 2D Nuclear Magnetic Resonance (NMR) spectroscopy. These compounds were not toxic to human peripheral blood mononuclear cells (PBMCs) at 10 μg/mL over 24 h, yet showed significant in vitro suppression of proinflammatory cytokines involved in the pathogenesis of inflammatory bowel disease (IBD). Specifically, the release of interferon γ (IFN-γ), interleukin (IL)-17A, and IL-8 from phorbol myristate acetate/ionomycin (P/I) and anti-CD3/anti-CD28-activated cells were significantly suppressed by compounds 4 and 5. Interestingly, no effect on tumour necrosis factor (TNF) release was observed. These results show that the newly characterised compound 4 has promising cytokine suppressive properties, which could be further investigated as a candidate for IBD treatment.

Topics: Anti-Inflammatory Agents; Australia; Cytokines; Glucosides; Humans; Inflammatory Bowel Diseases; Leukocytes, Mononuclear; Myrtaceae

Topics: Animals; Anti-Inflammatory Agents; Bifidobacterium; Colitis; Fruit; Inflammatory Bowel Diseases; Intestinal Mucosa; Lactobacillus; Myrtaceae; Plant Extracts; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid